KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
130 hedge funds and large institutions have $312M invested in Keryx Biopharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
16% less capital invested
Capital invested by funds: $369M → $312M (-$57.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
130
Holding in Top 10
–
Calls
$3.09M
Puts
$3.22M
Top Buyers
| 1 | +$1.43M | |
| 2 | +$1.02M | |
| 3 | +$933K | |
| 4 |
RA
Royce & Associates
New York
|
+$514K |
| 5 |
D.E. Shaw & Co
New York
|
+$481K |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$5.01M | |
| 3 | -$4.22M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.89M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$3.03M |